|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rebollo A and Martı́nez-A C: Ras proteins:
Recent advances and new functions. Blood. 94:2971–2980.
1999.PubMed/NCBI
|
|
3
|
Qiao F, Su X, Qiu X, Qian D, Peng X, Chen
H, Zhao Z and Fan H: Enforced expression of RASAL1 suppresses cell
proliferation and the transformation ability of gastric cancer
cells. Oncol Rep. 28:1475–1481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu D, Yang C, Bojdani E, Murugan AK and
Xing M: Identification of RASAL1 as a major tumor suppressor gene
in thyroid cancer. J Natl Cancer Inst. 105:1617–1627. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tao H, Huang C, Yang JJ, Ma TT, Bian EB,
Zhang L, Lv XW, Jin Y and Li J: MeCP2 controls the expression of
RASAL1 in the hepatic fibrosis in rats. Toxicology. 290:327–333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ko KS, Tomasi ML and Iglesiasas AL: MeCP2
controls the expression of RASAL1 in the hepatic fibrosis in rats.
Toxicology 290: Rosis, and hepatocellular carcinoma in mice.
Hepatology. 52:2096–2108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Semenza GL: Hypoxia-inducible factors:
Mediators of cancer progression and targets for cancer therapy.
Trends Pharmacol Sci. 33:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ryan HE, Poloni M, McNulty W, Elson D,
Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible
factor-1alpha is a positive factor in solid tumor growth. Cancer
Res. 60:4010–4015. 2000.PubMed/NCBI
|
|
9
|
Weidemann A and Johnson R: Biology of
HIF-1alpha. Cell Death Differ. 15:621–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Löfstedt T, Fredlund E,
Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L and
Påhlman S: Hypoxia inducible factor-2alpha in cancer. Cell Cycle.
6:919–926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng J, Zhang L, Drysdale L and Fong GH:
The transcription factor EPAS-1/hypoxia-inducible factor 2alpha
plays an important role in vascular remodeling. Proc Natl Acad Sci.
97:pp. 8386–8391. 2000, View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian H, Hammer RE, Matsumoto AM, Russell
DW and McKnight SL: The hypoxia-responsive transcription factor
EPAS1 is essential for catecholamine homeostasis and protection
against heart failure during embryonic development. Genes Dev.
12:3320–3324. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei K, Piecewicz SM, McGinnis LM,
Taniguchi CM, Wiegand SJ, Anderson K, Chan CW, Mulligan KX, Kuo D,
Yuan J, et al: A liver Hif-2 α-Irs2 pathway sensitizes hepatic
insulin signaling and is modulated by Vegf inhibition. Nat Med.
19:1331–1337. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taniguchi CM, Finger EC, Krieg AJ, Wu C,
Diep AN, LaGory EL, Wei K, McGinnis LM, Yuan J, Kuo CJ and Giaccia
AJ: Cross-talk between hypoxia and insulin signaling through Phd3
regulates hepatic glucose and lipid metabolism and ameliorates
diabetes. Nat Med. 19:1325–1330. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ramakrishnan SK, Zhang H, Takahashi S,
Centofanti B, Periyasamy S, Weisz K, Chen Z, Uhler MD, Rui L,
Gonzalez FJ and Shah YM: HIF2α is an essential molecular brake for
postprandial hepatic glucagon response independent of insulin
signaling. Cell Metab. 23:505–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DeBerardinis RJ, Sayed N, Ditsworth D and
Thompson CB: Brick by brick: Metabolism and tumor cell growth. Curr
Opin Genet Dev. 18:54–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sikes RS: The Animal Care and Use
Committee of the American Society of Mammalogists: 2016 Guidelines
of the American Society of Mammalogists for the use of wild mammals
in research and education. J Mammalogy. 97:663–688. 2016.
View Article : Google Scholar
|
|
18
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S
and Muramatsu T: A small interfering RNA targeting vascular
endothelial growth factor as cancer therapeutics. Cancer Res.
64:3365–3370. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McClain DA, Abuelgasim KA, Nouraie M,
Salomon-Andonie J, Niu X, Miasnikova G, Polyakova LA, Sergueeva A,
Okhotin DJ, Cherqaoui R, et al: Decreased serum glucose and
glycosylated hemoglobin levels in patients with Chuvash
polycythemia: A role for HIF in glucose metabolism. J Mol Med
(Berl). 91:59–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohta M, Seto M, Ijichi H, Miyabayashi K,
Kudo Y, Mohri D, Asaoka Y, Tada M, Tanaka Y, Ikenoue T, et al:
Decreased expression of the RAS-GTPase activating protein RASAL1 is
associated with colorectal tumor progression. Gastroenterology.
136:206–216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiao F, Su X, Qiu X, Qian D, Peng X, Chen
H, Zhao Z and Fan H: Enforced expression of RASAL1 suppresses cell
proliferation and the transformation ability of gastric cancer
cells. Oncol Rep. 28:1475–1481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin H, Wang X, Ying J, Wong AH, Cui Y,
Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, et al: Epigenetic
silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL
defines a new mechanism of Ras activation in human cancers. Proc
Natl Acad Sci USA. 104:pp. 12353–12358. 2007, View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kolfschoten IG, van Leeuwen B, Berns K,
Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami
R: A genetic screen identifies PITX1 as a suppressor of RAS
activity and tumorigenicity. Cell. 121:849–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen H, Yang XW, Zhang H, Yang Q, Wang Z,
Liu Y, Lu FL, Zhou BY, Qiu-Xi CH and Lu SL: In vivo and in vitro
expression of the RASAL1 gene in human gastric adenocarcinoma and
its clinicopathological significance. Oncol Lett. 3:535–540.
2012.PubMed/NCBI
|
|
27
|
Jin W, Chen L, Cai X, Zhang Y, Zhang J, Ma
D, Cai X, Fu T, Yu Z, Yu F and Chen G: Long non-coding RNA TUC338
is functionally involved in sorafenib-sensitized hepatocarcinoma
cells by targeting RASAL1. Oncol Rep. 37:273–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blancher C, Moore JW, Talks KL, Houlbrook
S and Harris AL: Relationship of hypoxia-inducible factor
(HIF)-1alpha and HIF-2alpha expression to vascular endothelial
growth factor induction and hypoxia survival in human breast cancer
cell lines. Cancer Res. 60:7106–7113. 2000.PubMed/NCBI
|
|
29
|
Beasley NJ, Leek R, Alam M, Turley H, Cox
GJ, Gatter K, Millard P, Fuggle S and Harris AL: Hypoxia-inducible
factors HIF-1alpha and HIF-2 alpha in head and neck cancer:
Relationship to tumor biology and treatment outcome in surgically
resected patients. Cancer Res. 62:2493–2497. 2002.PubMed/NCBI
|
|
30
|
Acker T, Diez-Juan A, Aragones J, Tjwa M,
Brusselmans K, Moons L, Fukumura D, Moreno-Murciano MP, Herbert JM,
et al: Genetic evidence for a tumor suppressor role of HIF-2alpha.
Cancer Cell. 8:131–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kondo K, Klco J, Nakamura E, Lechpammer M
and Kaelin WG Jr: Inhibition of HIF is necessary for tumor
suppression by the von Hippel-Lindau protein. Cancer Cell.
1:237–246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hur E, Chang KY, Lee E, Lee S-K and Park
H: Mitogen-activated protein kinase kinase inhibitor PD98059 blocks
the trans-activation but not the stabilization or DNA binding
ability of hypoxia-inducible factor-1alpha. Mol Pharmacol.
59:1216–1224. 2001.PubMed/NCBI
|
|
33
|
Rankin EB, Rha J, Selak MA, Unger TL,
Keith B, Liu Q and Haase VH: Hypoxia-inducible factor 2 regulates
hepatic lipid metabolism. Mol Cell Biol. 29:4527–4538. 2009.
View Article : Google Scholar : PubMed/NCBI
|
